Monoclonal Antibodies Against Human Papillomavirus E6 and E7 Oncoproteins Inhibit Tumor Growth in Experimental Cervical Cancer
Nearly all cases of cervical cancer are initiated by persistent infection with high-risk strains of human papillomavirus (hr-HPV). When hr-HPV integrates into the host genome, the constitutive expression of oncogenic HPV proteins E6 and E7 function to disrupt p53 and retinoblastoma regulation of cel...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-10-01
|
Series: | Translational Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S193652331930018X |
id |
doaj-7a79adf7076c4f8caf013fd250ed9164 |
---|---|
record_format |
Article |
spelling |
doaj-7a79adf7076c4f8caf013fd250ed91642020-11-25T01:16:24ZengElsevierTranslational Oncology1936-52332019-10-01121012891295Monoclonal Antibodies Against Human Papillomavirus E6 and E7 Oncoproteins Inhibit Tumor Growth in Experimental Cervical CancerZewei Jiang0Joseph Albanese1Joshua Kesterson2Joshua Warrick3Rouzan Karabakhtsian4Ekaterina Dadachova5Rébécca Phaëton6Albert Einstein College of Medicine, Montefiore Medical Center, Department of Radiology, 1300 Morris Park Avenue, Bronx, NY 10461, United StatesAlbert Einstein College of Medicine, Montefiore Medical Center, 111 East 210th Street Avenue, Bronx, NY 10467, United StatesPenn State College of Medicine, Milton S. Hershey Medical Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, 500 University Avenue, Mail Code H103, Hershey, PA 17033Penn State College of Medicine, Milton S. Hershey Medical Center, Department of Pathology, 500 University Avenue, Hershey, PA 17033, United StatesAlbert Einstein College of Medicine, Montefiore Medical Center, 1300 Morris Park Avenue, Bronx, NY 10461, United StatesUniversity of Saskatchewan, College of Pharmacy and Nutrition, 107 Wiggins Rd, Health Sciences Blvd, Box 3D01-11, Saskatoon, Saskatchewan, S7N 5E5, CanadaPenn State College of Medicine, Departments of Obstetrics and Gynecology and Microbiology and Immunology, Division of Gynecologic Oncology, 500 University Drive, Mail Code H103, Hershey, PA 17033; Corresponding author at: Department of Obstetrics and Gynecology and Microbiology and Immunology, Division of Gynecologic Oncology 500 University Drive, Hershey, PA 17033, United States.Nearly all cases of cervical cancer are initiated by persistent infection with high-risk strains of human papillomavirus (hr-HPV). When hr-HPV integrates into the host genome, the constitutive expression of oncogenic HPV proteins E6 and E7 function to disrupt p53 and retinoblastoma regulation of cell cycle, respectively, to favor malignant transformation. HPV E6 and E7 are oncogenes found in over 99% of cervical cancer, they are also expressed in pre-neoplastic stages making these viral oncoproteins attractive therapeutic targets. Monoclonal antibodies (mAbs) represent a novel potential approach against the actions of hr-HPV E6 and E7 oncoproteins.In this report, we describe the utilization of anti-HPV E6 and HPV E7 mAbs in an experimental murine model of human cervical cancer tumors. We used differential dosing strategies of mAbs C1P5 (anti-HPV 16 E6) and TVG701Y (anti-HPV E7) administered via intraperitoneal or intratumoral injections. We compared mAbs to the action of chemotherapeutic agent Cisplatin and demonstrated the capacity of mAbs to significantly inhibit tumor growth. Furthermore, we investigated the contribution of the immune system and found increased complement deposition in both C1P5 and TVG701Y treated tumors compared to irrelevant mAb therapy. Taken together, the results suggest that anti-HPV E6 and E7 mAbs exert inhibition of tumor growth in a viral-specific manner and stimulate an immune response that could be exploited for an additional treatment options for patients. Keywords: cervical cancer, monoclonal antibodies, HPV E6 and E7, immunotherapy, nude micehttp://www.sciencedirect.com/science/article/pii/S193652331930018X |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Zewei Jiang Joseph Albanese Joshua Kesterson Joshua Warrick Rouzan Karabakhtsian Ekaterina Dadachova Rébécca Phaëton |
spellingShingle |
Zewei Jiang Joseph Albanese Joshua Kesterson Joshua Warrick Rouzan Karabakhtsian Ekaterina Dadachova Rébécca Phaëton Monoclonal Antibodies Against Human Papillomavirus E6 and E7 Oncoproteins Inhibit Tumor Growth in Experimental Cervical Cancer Translational Oncology |
author_facet |
Zewei Jiang Joseph Albanese Joshua Kesterson Joshua Warrick Rouzan Karabakhtsian Ekaterina Dadachova Rébécca Phaëton |
author_sort |
Zewei Jiang |
title |
Monoclonal Antibodies Against Human Papillomavirus E6 and E7 Oncoproteins Inhibit Tumor Growth in Experimental Cervical Cancer |
title_short |
Monoclonal Antibodies Against Human Papillomavirus E6 and E7 Oncoproteins Inhibit Tumor Growth in Experimental Cervical Cancer |
title_full |
Monoclonal Antibodies Against Human Papillomavirus E6 and E7 Oncoproteins Inhibit Tumor Growth in Experimental Cervical Cancer |
title_fullStr |
Monoclonal Antibodies Against Human Papillomavirus E6 and E7 Oncoproteins Inhibit Tumor Growth in Experimental Cervical Cancer |
title_full_unstemmed |
Monoclonal Antibodies Against Human Papillomavirus E6 and E7 Oncoproteins Inhibit Tumor Growth in Experimental Cervical Cancer |
title_sort |
monoclonal antibodies against human papillomavirus e6 and e7 oncoproteins inhibit tumor growth in experimental cervical cancer |
publisher |
Elsevier |
series |
Translational Oncology |
issn |
1936-5233 |
publishDate |
2019-10-01 |
description |
Nearly all cases of cervical cancer are initiated by persistent infection with high-risk strains of human papillomavirus (hr-HPV). When hr-HPV integrates into the host genome, the constitutive expression of oncogenic HPV proteins E6 and E7 function to disrupt p53 and retinoblastoma regulation of cell cycle, respectively, to favor malignant transformation. HPV E6 and E7 are oncogenes found in over 99% of cervical cancer, they are also expressed in pre-neoplastic stages making these viral oncoproteins attractive therapeutic targets. Monoclonal antibodies (mAbs) represent a novel potential approach against the actions of hr-HPV E6 and E7 oncoproteins.In this report, we describe the utilization of anti-HPV E6 and HPV E7 mAbs in an experimental murine model of human cervical cancer tumors. We used differential dosing strategies of mAbs C1P5 (anti-HPV 16 E6) and TVG701Y (anti-HPV E7) administered via intraperitoneal or intratumoral injections. We compared mAbs to the action of chemotherapeutic agent Cisplatin and demonstrated the capacity of mAbs to significantly inhibit tumor growth. Furthermore, we investigated the contribution of the immune system and found increased complement deposition in both C1P5 and TVG701Y treated tumors compared to irrelevant mAb therapy. Taken together, the results suggest that anti-HPV E6 and E7 mAbs exert inhibition of tumor growth in a viral-specific manner and stimulate an immune response that could be exploited for an additional treatment options for patients. Keywords: cervical cancer, monoclonal antibodies, HPV E6 and E7, immunotherapy, nude mice |
url |
http://www.sciencedirect.com/science/article/pii/S193652331930018X |
work_keys_str_mv |
AT zeweijiang monoclonalantibodiesagainsthumanpapillomaviruse6ande7oncoproteinsinhibittumorgrowthinexperimentalcervicalcancer AT josephalbanese monoclonalantibodiesagainsthumanpapillomaviruse6ande7oncoproteinsinhibittumorgrowthinexperimentalcervicalcancer AT joshuakesterson monoclonalantibodiesagainsthumanpapillomaviruse6ande7oncoproteinsinhibittumorgrowthinexperimentalcervicalcancer AT joshuawarrick monoclonalantibodiesagainsthumanpapillomaviruse6ande7oncoproteinsinhibittumorgrowthinexperimentalcervicalcancer AT rouzankarabakhtsian monoclonalantibodiesagainsthumanpapillomaviruse6ande7oncoproteinsinhibittumorgrowthinexperimentalcervicalcancer AT ekaterinadadachova monoclonalantibodiesagainsthumanpapillomaviruse6ande7oncoproteinsinhibittumorgrowthinexperimentalcervicalcancer AT rebeccaphaeton monoclonalantibodiesagainsthumanpapillomaviruse6ande7oncoproteinsinhibittumorgrowthinexperimentalcervicalcancer |
_version_ |
1725149892385439744 |